Results 101 to 110 of about 15,403 (196)

Evaluation of bioequivalence of two tablet forms of lisinopril in healthy volunteers

open access: yesФармакокинетика и Фармакодинамика, 2013
Under cross, single, open, randomized trial with 1 week washout period, with two sequences of 18 volunteers studied bioequivalence coated tablets, two manufacturers of lisinopril (20 mg dose).
S. A. Altynbekov   +5 more
doaj  

Safety and tolerability of the ACE-inhibitor lisinopril among Nigerian adults with HIV: preliminary pilot data from a randomized clinical trial. [PDF]

open access: yesNaunyn Schmiedebergs Arch Pharmacol
Dankishiya FS   +13 more
europepmc   +1 more source

PERBANDINGAN PENURUNAN TEKANAN DARAH PASIEN HIPERTENSI SETELAH PEMBERIAN LISINOPRIL MALAM ATAU PAGI HARI

open access: yes, 2014
Lisinopril is drug choice for hypertension therapy that works by inhibiting the action of angiotensin-converting enzyme (ACE). In 2011, research about the effect of circadian rhythms on the renin-angiotensin system proves that the main target of anti ...
, Annisa Nadya Utami   +1 more
core  

Lisinopril tabletták hatóanyagtartalom meghatározási módszerének fejlesztése és validálása

open access: yes, 2018
Lisinopril tabletták hatóanyagtartalom meghatározási módszerének fejlesztése és validálása.gjvegyészmérnök (gyógyszeripari specializáció)MSc ...
Hartman, Éva Tünde
core  

Lisinopril activates BI1 to reprogram lipid metabolism and restore autophagy in ALS. [PDF]

open access: yesCommun Biol
Yin H   +8 more
europepmc   +1 more source

A double-blind comparison of lisinopril with captopril in patients with symptomatic congestive heart failure

open access: yes, 1987
Angiotensin-converting enzyme (ACE) inhibition with captopril is accepted therapy for the treatment of symptomatic congestive heart failure. In this trial, we compared the new ACE inhibitor, lisinopril, to captopril during a 12-week randomized double ...
Powers, E. R.   +9 more
core  

Home - About - Disclaimer - Privacy